Pharma success increasingly depends on proving value

05/15/2013 | PharmaTimes (U.K.)

A drug's success in the marketplace increasingly depends on the drugmaker's ability to prove value and additional benefit over existing pharmaceuticals, yet many drugmakers still take a blockbuster approach to development, an international survey by Camelot Management Consultants finds. Germany and the U.K. are among the nations linking reimbursement price to additional benefit, which drives pricing elsewhere.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC